Insulin-like growth factor (IGF) binding protein-3 regulation of igf-i is altered in an acidic extracellular environment

Journal of Cellular Physiology

Volumn 189, Issue 3, 2001, Pages 356-365

  Forsten, Kimberly E ^a   Michael Akers, R ^b   San Antonio, James D ^c  

^a State University   (United States)

^b VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

^c THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; HEPARIN LYASE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ACIDIFICATION; ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CELL SURFACE; CONTROLLED STUDY; INTERNALIZATION; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR BINDING;

ANIMALS; CATTLE; CELL DIVISION; CELL LINE; CELL MEMBRANE; CELL NUCLEUS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SPACE; HEPARIN; HYDROGEN-ION CONCENTRATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; NEOPLASMS; POLYSACCHARIDE-LYASES;

EID: 0035159251     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.10033     Document Type: Article

References (67)

1. Radioimmunoassay for measurement of alpha-lactoferrin in serum, milk, and cultue media
2. Heparin modulates the binding of insulin-like growth factor (IGF) binding protein-5 to a membrane protein in osteoblastic cells
3. Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes
4. Measurement of insulin-like growth factor (IGF)-II binding to purified IGF binding proteins 1-6: Comparison of charcoal adsorption and high performance size exclusion chromatography
5. Glycosaminoglycans inhibit formation of the 140 kDa insulin-like growth factor-binding protein complex
6. The roles of tyrosines 24, 31, and 60 in the high affinity binding of insulin-like growth factor-I to the type 1 insulin-like growth factor receptor
7. The critical role of Shc in insulin-like growth factor-I-mediated mitogenesis and differentiation in 3T3-L1 preadipocytes
8. IGFBP-3 and IGFBP-5 association with endothelial cells: Role of the C-terminal heparin binding domain
9. IGFBP-3 proteolysis by plasmin, thrombin, serum: Heparin binding, IGF binding, and structure of fragments
10. Insulin-like growth factor-binding protein-3 binds fibrinogen
11. Variables controlling somatomedin production by cultured human fibroblasts
12. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: Studies of underlying mechanisms
13. Endogenous cathepsin D-mediated hydrolysis of insulin-like growth factor-binding proteins in cultured human prostatic carcinoma cells
14. Factors regulating insulin-like growth factor-binding protein-3 binding, processing, and potentiation of insulin-like growth factor action
15. Insulin-like growth factor (IGF) binding protein-3 potentiation of IGF action is mediated through the phosphatidylinositol-3-kinase pathway and is associated with alteration in protein kinase B/AKT sensitivity
16. The insulin-like growth factor I receptor induces transformation and tumor-igenicity of ovarian mesothelial cells and down-regulates their fas-receptor expression
17. Differential effects of insulin-like gowth factor (IGF)-binding protein-3 and its proteolytic fragments on ligand binding, cell surface association, and IGF-I receptor signaling
18. Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): Positive correlation with the presence of the GH-induced IGF-binding protein-3
19. The role of glycosylation in the action of IGFBP-3
20. Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3
21. Insulin-like growth factor-binding protein (IGFBP-3) predisposes breast cancer cells to programmed cell death in a non-IGF-dependent manner
22. Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II
23. Insulin-like growth factor binding protein-3 mediates IGF-I action in a bovine mammary epithelial cell line independent of an IGF interaction
24. Identification of the major sites of phosphorylation in IGF binding protein-3
25. Nuclear localization of insulin-like growth factor binding protein 3 in a lung cancer cell line
26. Insulin-like growth factor-1 and -2 stimulate osteoprogenitor proliferation and differentiation and adipocyte formation in cell populations derived from adult rat bone
27. Insulin-like growth factors and their binding proteins: Biological actions
28. Fractionation of low molecular weight heparin species and their interactions with antithrombin
29. Membrane-associated insulin-like growth factor-binding protein-3 inhibits insulin-like growth factor-I-induced insulin-like growth factor-I receptor signaling in Ishikawa endometrial cancer cells
30. Solid-phase assay for insulin-like growth factor (IGF) binding to IGF-binding protein-3: Application to the study of the effects of antibodies and heparin
31. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells
32. A proteolytic fragment of insulin-like growth factor (IGF) binding protein-3 that fails to bind IGFs inhibits the mitogenic effects of IGF-I and insulin
33. The molecular-weight dependence of the anti-coagulant activity of heparin
34. The type V transforming growth factor β receptor is the putative insulin-like growth factor-binding protein 3 receptor
35. Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: Development of a sensitive electrophoretic approach
36. Proteolysis of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in 150-kilodalton IGFBP complexes by a cation-dependent protease activity in adult rat serum promotes the release of bound IGF-I
37. Molecular and cellular aspects of the insulin-like growth factor I receptor
38. Oncogenic ras causes resistance to the growth inhibitor insulin-like growth factor binding protein-3 (IGFBP-3) in breast cancer cells
39. Insulin-like growth factor-I (IGF-I) and transforming growth factor-B1 release IGF-binding protein-3 from human fibroblasts by different mechanisms
40. Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: The modulating effect of cell released IGF binding proteins (IGFBPs)
41. Insulin-like growth factor (IGF) binding to cell monolayers is directly modulated by the addition of IGF-binding proteins
42. Insulin-like growth factor I-triggered cell migration and invasion are mediated by matrix metalloprotease-9
43. Breast cancer cells have a high capacity to acidify extracellular milieu by a dual mechanism
44. Kinetics of basic fibroblast growth factor binding to its receptor and heparan sulfate proteoglycan: A mechanism for cooperativity
45. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells
46. Exploitation of the tumor microenvironment for creation of selective antitumor drugs
47. Insulin-like growth factor binding proteins (IGFBPs) in breast cancer
48. Variation among cell types in the signaling pathways by which IGF-I stimulates Specific cellular responses
49. Insulin-like growth factor (IGF)-binding protein-3 induces apoptosis and mediates the effects of transforming growth factor-β1 on programmed cell death through a p53- and IGF-independent mechanism
50. Real-time detection of IGF-I stimulation of the MAC-T bovine mammary epithelial cell line
51. IGF-I induced IGFBP-3 potentiates the mitogenic action of IGF-I in mammary epithelial MD-IGF-I cells
52. Regulation of expression of IGF-I-iduced IGFBP-3 and IGF-I-receptor by constitutive vs. regulated expression of recombinant IGF-I in transfected mammary epithelial cells
53. Specificity in the interactions of extracellular matrix proteins with subpopulations of the glycosaminoglycan heparin
54. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells
55. Mechanisms of sertoli cell insulin-like growth factor(IGF)-binding protein-3 regulation by IGF-I and adenosine 3′,5′-monophosphate
56. Insulin-like growth factor-binding protein-3 (IGFBP-3) concentration in rat sertoli cell-conditioned medium is regulated by a pathway involving association of IGFBP-3 with cell surface proteoglycans
57. Causes and consequences of tumour acidity and implications for treatment
58. Autocrine regulation of human tumor cell proliferation by insulin-like growth factor II: An in vitro model
59. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review
60. Characterization of transforming growth factor-b growth regulatory effects and receptors on bovine mammary cells
61. The insulin-like growth factor-phosphatidylinositol 3-kinase-Akt signaling pathway regulates myogenin expression in normal myogenic cells but not in rhabdomyosarcoma-derived RD cells
62. Characterization of insulin-like growth factor binding protein-3 (IGFBP-3) binding to human breast cancer cells: Kinetics of IGFBP-3 binding and identification of receptor binding domain on the IGFBP-3 molecule
63. Heparin inhibition of insulin-like growth factor-binding protein-3 binding to human fibroblasts and rat glioma cells: Role of heparan sulfate proteoglycans
64. Crosstalk between the insulin-like groth factors and estrogens in breast cancer
65. Insulin-like growth factor binding protein-3 inhibits gonadotropin-induced ovulation, oocyte maturation, and steroidogenesis in rabbit ovary
66. Expression of eukaryotic proteins in soluble form in Escherichia coli
67. Receptor binding and growth-promoting activity of insulin-like growth factor-I in a bovine mammary epithelial cell line (MAC-T3)